New study shows why remdesivir works against SARS-CoV-2 but not on other viruses like the flu

Matthias Götte led new research showing for the first time why the antiviral drug remdesivir is effective against some viruses, including SARS-CoV-2, but not against others — which will help develop broad-spectrum treatments against both existing and new viruses. (Photo: John Ulan) Matthias Götte led new research showing for the first time why the antiviral drug remdesivir is effective against some viruses, including SARS-CoV-2, but not against others — which will help develop broad-spectrum treatments against both existing and new viruses. (Photo: John Ulan)

New study shows why remdesivir works against SARS-CoV-2 but not on other viruses like the flu

Understanding interactions between drugs and viruses will be key to building better antivirals and being ready for the next pandemic, says researcher.

Understanding exactly how antiviral drugs interact with viruses at a molecular level will be key to developing the broad-spectrum therapies needed to battle against the SARS-CoV-2 pandemic and get ready to fight the next one, according to a newly published paper in the The Journal of Biological Chemistry....

https://www.ualberta.ca/folio/2022/01/building-better-antivirals.html